MAD1L1 Antikörper (AA 1-50)
Kurzübersicht für MAD1L1 Antikörper (AA 1-50) (ABIN1911151)
Target
Alle MAD1L1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-50
-
Spezifität
- Region between residues 1 and 50 of human Mitotic arrest deficient-like 1 using the numbering given in Swiss-Prot entry Q9Y6D9 (GeneID 8379).
-
Aufreinigung
- Immunoaffinity purified
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: IF (1:250 - 1:1000), IHC, IHC-P (1:500 - 1:2000), IP (1 - 4 μg/mg lysate), PLA (1:1000 - 1:20000), WB (1:5000 - 1:15000)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Human controls: Breast Carcinoma, Laryngeal Squamous Cell Carcinoma, Prostate Carcinoma. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Tris-citrate/phosphate buffer, pH 7-8, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8°C for up to 1 year.
-
Haltbarkeit
- 12 months
-
-
- MAD1L1 (MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1))
-
Andere Bezeichnung
- MAD1L1 / MAD1
-
Hintergrund
-
Name/Gene ID: MAD1L1
Synonyms: MAD1L1, HMAD1, MAD1, MAD1-like protein 1, Tax-binding protein 181, TP53I9, PIG9, HSMAD1, Tax1-binding protein txbp181, TXBP181 -
Gen-ID
- 8379
-
Pathways
- M Phase
Target
-